Schonfeld Strategic Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-592,847
Closed -$60.2M 2358
2025
Q4
$60.2M Buy
+592,847
New +$47.6M 0.27% 43
2025
Q3
Sell
-319,311
Closed -$17M 2311
2025
Q2
$17M Buy
319,311
+299,041
+1,475% +$15.2M 0.12% 202
2025
Q1
$877K Sell
20,270
-1,438
-7% -$72.8K 0.01% 1341
2024
Q4
$1.22M Buy
21,708
+17,231
+385% +$1.07M 0.01% 1032
2024
Q3
$305K Buy
+4,477
New +$253K ﹤0.01% 1646
2024
Q1
Sell
-21,507
Closed -$1.59M 2157
2023
Q4
$1.59M Buy
21,507
+17,967
+508% +$1.18M 0.01% 879
2023
Q3
$241K Sell
3,540
-5,110
-59% -$434K ﹤0.01% 1372
2023
Q2
$812K Buy
+8,650
New +$675K 0.01% 1050
2023
Q1
Sell
-9,740
Closed -$482K 2245
2022
Q4
$482K Sell
9,740
-4,773
-33% -$195K ﹤0.01% 1547
2022
Q3
$471K Buy
+14,513
New +$598K ﹤0.01% 1797
2021
Q1
Sell
-11,812
Closed -$1.56M 1886
2020
Q4
$1.56M Buy
+11,812
New +$1.43M 0.02% 666
2020
Q3
Sell
-10,032
Closed -$873K 1440
2020
Q2
$873K Sell
10,032
-18,525
-65% -$1.48M 0.02% 640
2020
Q1
$1.66M Sell
28,557
-53,844
-65% -$4.37M 0.1% 236
2019
Q4
$7.62M Buy
82,401
+72,926
+770% +$6.41M 0.19% 139
2019
Q3
$856K Buy
+9,475
New +$1.08M 0.03% 504
2018
Q4
Sell
-19,100
Closed -$1.51M 1117
2018
Q3
$1.51M Buy
+19,100
New +$1.25M 0.07% 343
2017
Q2
Sell
-26,119
Closed -$616K 653
2017
Q1
$616K Buy
+26,119
New +$518K 0.06% 333
2016
Q4
Sell
-69,234
Closed -$1.29M 578
2016
Q3
$1.29M Buy
+69,234
New +$1.22M 0.22% 130

Other funds holding EXAS

Schonfeld Strategic Advisors's EXAS Position: Q1 2026 in Review

Schonfeld Strategic Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 592,847 shares — an estimated $60.2M sold.

Schonfeld Strategic Advisors first reported a position in EXAS in Q3 2016 and held it in 18 quarters. The position peaked at $60.2M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Schonfeld Strategic Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 592,847 Exact Sciences shares in Q1 2026, an estimated $60.2M.
  • Schonfeld Strategic Advisors first reported a position in Exact Sciences in Q3 2016 and held it in 18 quarters.
  • Schonfeld Strategic Advisors's Exact Sciences position peaked at $60.2M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.